LADUNGOVÁ, Adriana, Daniel BUŠA, Yusuf LODHI, Jan HÝL, Martin ČULEN and Michal ŠMÍDA. Prediction of novel treatment options for venetoclax-resistant AML cells based on drug repurposing. In Functional Precision Medicine for Blood Cancer Workshop and Symposium, Helsinki, Finland. 2022.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Prediction of novel treatment options for venetoclax-resistant AML cells based on drug repurposing.
Authors LADUNGOVÁ, Adriana, Daniel BUŠA, Yusuf LODHI, Jan HÝL, Martin ČULEN and Michal ŠMÍDA.
Edition Functional Precision Medicine for Blood Cancer Workshop and Symposium, Helsinki, Finland, 2022.
Other information
Type of outcome Conference abstract
Confidentiality degree is not subject to a state or trade secret
Organization unit Central European Institute of Technology
Changed by Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 20/1/2023 15:26.
PrintDisplayed: 24/7/2024 16:34